A Study to Evaluate A Wearable Sensor to Study Baseball Pitching

Overview

About this study

The purpose of this study is to assess the validity and reliability of a wearable device, the MotusBASEBALL sensor, against a marker-based motion capture, Motion Analysis Corp., for assessing baseball pitchers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 15-30 years, inclusive.
  • Male gender.
  • Active participation in competitive baseball as a pitcher.Should be competing at the high school or collegiate level.
  • No current musculoskeletal complaints for which the subject is being treated.
  • Full pain-free range of motion (ROM) of the bilateral upper and lower limbs.
  • Willingness to participate in the study

Exclusion Criteria: 

  • Current upper limb, lower limb, or spine musculoskeletal pain complaint for which the subject is taking prescribed medication, has modified activity, or received treatment from a medical care provider.
  • History of fracture, dislocation, subluxation, or separation affecting the cervical spine, thoracic spine, rib cage, elbow, or either shoulder girdle.
  • History of rotator cuff injury, elbow injury, or shoulder instability for which the subject has been evaluated and/or treated in the past 12 months.
  • History of dominant side shoulder or elbow surgery.
  • Known neurological, visual, or vestibular disease affecting balance or coordination
  • Congenital deformity of the neck, upper extremity, or lower extremity.
  • Congenital or acquired scoliosis or significant thoracic kyphosis (> 30 degrees).
  • History of connective tissue disease (defined as rheumatoid arthritis, systemic lupus erythematosus, or a seronegative spondylarthropathy).

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Christopher Camp, M.D.

Closed for enrollment

Contact information:

Daniel Christoffer L.A.T., A.T.C.

(507)266-6690

Christoffer.Daniel@mayo.edu

More information

Publications

Publications are currently not available